SARS-CoV-2 inactivated vaccine (medium-dosage booster)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SARS-CoV-2 inactivated vaccine (medium-dosage booster), covering 2022-03-02 to 2022-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19 [Phase 4]